A Study of Attitudes About the Risk of Developing Type 2 Diabetes
Cues to Action in Diabetes Risk Education (CADRE): Randomized Study Assessing the Impact of Knowledge of Impaired Glucose Tolerance on Perceived Risk and Behavior Change Motivation
1 other identifier
interventional
276
1 country
2
Brief Summary
Diabetes mellitus (DM) type 2 is well recognized as a major cause of morbidity and mortality in the United States, as well as a significant contributor to health disparities within the population. Changes in demographic and lifestyle characteristics in the population have led to a progressive increase in the prevalence of both diabetes and impaired glucose tolerance (IGT), a precursor to DM type 2. Although pharmacologic interventions have proven to be successful in blocking the progression from IGT to DM, they have not been as effective as diet and exercise modification. Studies of behavioral interventions in IGT have focused on the outcomes of improved DM risk factors and decreased progression to DM, but have either required extensive interventions that lack applicability to the general population or have utilized more modest interventions with no effect on risk factors. These studies have not included impact evaluations to assess the effect of knowledge of IGT status on motivation to change and perceived risk. This study will assess the impact of knowledge of IGT on the likelihood of altering health-related behaviors, utilizing the Health Belief Model as a conceptual framework. Subjects will be randomized to one of four treatment arms, organized in a factorial design to (1) assess the impact of OGTT testing on motivation to change behaviors and (2) evaluate the efficacy of a novel educational intervention linked to patients' learning styles. This evaluation will determine whether OGTT testing is more beneficial as a cue to action to motivate behavior change than a multifactorial assessment of diabetes risk. Additionally, the improvement in health motivation after an educational intervention is expected to be enhanced when the educational method is tailored to the individual's preferred learning style. This information will provide the foundation for more efficient behavioral interventions for patients at high risk for DM type 2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2003
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2004
CompletedFirst Submitted
Initial submission to the registry
May 6, 2006
CompletedFirst Posted
Study publicly available on registry
May 9, 2006
CompletedJune 28, 2007
June 1, 2007
May 6, 2006
June 27, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Scores on perceived risk scale after the intervention
Scores on motivation to change behavior scale after the intervention
Secondary Outcomes (2)
Scores on scales of perceived benefits of healthy lifestyle choices
Scores on scales of perceived barriers to healthy lifestyle choices
Interventions
Eligibility Criteria
You may qualify if:
- Increased risk for diabetes type 2 by one of the following characteristics: (1) BMI\>30, (2) Age\>45, (3) First-degree relative with type 2 diabetes, (4) History of gestational diabetes, (5) Prior elevated fasting glucose in the previous year.
You may not qualify if:
- History of diabetes (not gestational diabetes)
- Current laboratory results consistent with diabetes
- Current pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ghent Family Practice
Norfolk, Virginia, 23507, United States
Portsmouth Family Medicine
Portsmouth, Virginia, 23707, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura E Eizember, MD
Eastern Virginia Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 6, 2006
First Posted
May 9, 2006
Study Start
April 1, 2003
Study Completion
December 1, 2004
Last Updated
June 28, 2007
Record last verified: 2007-06